Iloprost modulates the immune response in systemic sclerosis

被引：0
|
作者：
Patrizia D'Amelio
Maria A Cristofaro
Lucia D'Amico
Luciana Veneziano
Ilaria Roato
Francesca Sassi
Giuseppina Bisignano
Marta Saracco
Raffaele Pellerito
Salvatore Patanè
Riccardo Ferracini
Gian P Pescarmona
Giovanni C Isaia
机构：
[1] University of Torino,Gerontology Section, Department of Surgical and Medical Disciplines
[2] A.O.U. San Giovanni Battista,CeRMS (Center for Research and Medical Studies)
[3] Division of rheumatology "Ordine Mauriziano" Hospital,Department of Orthopaedics
[4] A.O.U. San Giovanni Battista,Department of Genetics
[5] Biology and Biochemistry - University of Torino,undefined
来源：
BMC Immunology | / 11卷
关键词：
Treg Cell; Connective Tissue Growth Factor; Iloprost; Critical Limb Ischemia; Skin Fibrosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] MICROCIRCULATORY EFFECTS OF ILOPROST ON NEW DIGITAL ULCERS INPATIENTS WITH SYSTEMIC SCLEROSIS
    Pintaudi, C.
    Cimino, R.
    Giancotti, S.
    Mazzuca, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S76 - S76
  • [32] Systemic isotretinoin treatment modulates patients' immune response to P. acnes
    Dispenza, Melanie
    Nelson, Amanda
    Gilliland, Kathryn
    Cong, Zhaoyuan
    Thiboutot, Diane
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [33] ILOPROST INDUCED WEIGHT LOST AND MALNUTRITION IN SYSTEMIC SCLEROSIS PATIENT: A CASE REPORT
    Bruno, C.
    Naty, S.
    Abenavoli, L.
    Grembiale, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S104 - S104
  • [34] Iloprost effects on phenotypic activation of circulating T cells in patients with systemic sclerosis
    Bellissimo, S
    Iannone, F
    Covelli, M
    Lapadula, G
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 459 - 459
  • [35] Iloprost effects on the expression of adhesion molecules and T cell proliferaton in systemic sclerosis
    Rehberger, P.
    Beckheinrich, P.
    Haustein, U.
    Sticherling
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 429 - 429
  • [36] A case of diffuse systemic sclerosis treated with a 28-day infusion of iloprost
    D. Biasi
    P. Caramaschi
    A. Carletto
    S. Zeminian
    F. Schiavon
    L. M. Bambara
    Clinical Rheumatology, 1997, 16 : 111 - 112
  • [37] Iloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosis
    Erre, G. L.
    De Muro, P.
    Dellaca, P.
    Fenu, P.
    Cherchi, G. M.
    Faedda, R.
    Passiu, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (06) : 1095 - 1098
  • [38] Iloprost prevents chronic renal vascular functional damage in systemic sclerosis (SSc)
    Livi, R
    Miniati, I
    Nacci, F
    Pignone, A
    Matucci-Cerinic, M
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 226 - 226
  • [39] Effect of iloprost infusion on the resistance index of renal vessels of patients with systemic sclerosis
    Scorza, R
    Rivolta, R
    Mascagni, B
    Berruti, V
    Bazzi, S
    Castagnone, D
    DiPalo, FQ
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (10) : 1944 - 1948
  • [40] Paradoxical Raynaud's phenomenon following iloprost infusion in a patient with systemic sclerosis
    Bertelle, D.
    Bertoldo, E.
    Bixio, R.
    Rossini, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 (01) : 91 - 92
12345